1. Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003;21:1352–1358.
2. Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989;321:784–789.
4. Swerdlow SH, Webber SA, Chadburn A, et al. Posttransplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Sterin H, Thiele J, Vardiman JW, eds. The World Health Organization Classification of Neoplastic Diseases of the Haematopoietic and Lymphoid Tissues Lyon: IARC; 2008;343–349.
6. Lee HY, Ko SA, Sohn SH, et al. A case of posttransplantation lymphoproliferative disorder in hematopoietic stem cell transplantation. Korean J Med 2009;77:172–178.
7. Lee SM, Kim KH, Kang MJ, Choi MY, Lee WS, Joo YD. Hodgkin's lymphoma-like posttransplantation lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation. Korean J Hematol 2009;44:278–283.
10. Rowlings PA, Curtis RE, Passweg JR, et al. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol 1999;17:3122–3127.